Enjoji M - Search Results

1

Urinary N',N'2-diacetylspermine levels correlate with HCV amount in patients with chronic hepatitis C.

Enjoji M, Arimura E, Kohjima M, Kotoh K, Nakamuta M. Enjoji M, et al. Int J Biol Markers. 2005 Apr-Jun;20(2):137-8. Int J Biol Markers. 2005. PMID: 16011046 No abstract available.

2

Clinical significance of urinary N1,N12-diacetylspermine levels in patients with hepatocellular carcinoma.

Enjoji M, Nakamuta M, Arimura E, Morizono S, Kuniyoshi M, Fukushima M, Kotoh K, Nawata H. Enjoji M, et al. Int J Biol Markers. 2004 Oct-Dec;19(4):322-7. doi: 10.1177/172460080401900411. Int J Biol Markers. 2004. PMID: 15646840 Free article.

3

Urinary N1,N12-diacetylspermine levels correlate with HCV amount in patients with chronic hepatitis C.

Enjoji M, Arimura E, Kohjima M, Kotoh K, Nakamuta M. Enjoji M, et al. Int J Biol Markers. 2005 Apr-Jun;20(2):137-138. doi: 10.5301/JBM.2008.1746. Int J Biol Markers. 2005. PMID: 28207140 Free article.

4

[Factors affecting the increase of urinary diacetylspermine levels : a study in patients with liver diseases].

Enjoji M, Kotoh K, Nakamuta M; Kyushu Diacetylspermine Study Group. Enjoji M, et al. Rinsho Byori. 2006 Feb;54(2):126-31. Rinsho Byori. 2006. PMID: 16548232 Review. Japanese.

5

Therapeutic effect of ARBs on insulin resistance and liver injury in patients with NAFLD and chronic hepatitis C: a pilot study.

Enjoji M, Kotoh K, Kato M, Higuchi N, Kohjima M, Nakashima M, Nakamuta M. Enjoji M, et al. Int J Mol Med. 2008 Oct;22(4):521-7. Int J Mol Med. 2008. PMID: 18813860 Clinical Trial.

6

Various sarcoid lesions in a patient induced by interferon therapy for chronic hepatitis C.

Noguchi K, Enjoji M, Nakamuta M, Sugimoto R, Kotoh K, Nawata H. Noguchi K, et al. Among authors: enjoji m. J Clin Gastroenterol. 2002 Sep;35(3):282-4. doi: 10.1097/00004836-200209000-00018. J Clin Gastroenterol. 2002. PMID: 12192210 No abstract available.

7

Changes in the expression of cholesterol metabolism-associated genes in HCV-infected liver: a novel target for therapy?

Nakamuta M, Yada R, Fujino T, Yada M, Higuchi N, Tanaka M, Miyazaki M, Kohjima M, Kato M, Yoshimoto T, Harada N, Taketomi A, Maehara Y, Koga M, Nishinakagawa T, Nakashima M, Kotoh K, Enjoji M. Nakamuta M, et al. Among authors: enjoji m. Int J Mol Med. 2009 Dec;24(6):825-8. doi: 10.3892/ijmm_00000299. Int J Mol Med. 2009. PMID: 19885625

8

Beta-lipoproteins influence the serum level of hepatitis C virus.

Enjoji M, Nakamuta M, Kinukawa N, Sugimoto R, Noguchi K, Tsuruta S, Iwao M, Kotoh K, Iwamoto H, Nawata H. Enjoji M, et al. Med Sci Monit. 2000 Sep-Oct;6(5):841-4. Med Sci Monit. 2000. PMID: 11208419

9

[Estimation of indication for living donor liver transplantation in patients with HCV and/or HBV infection].

Inoue S, Morizono S, Yamashita S, Horikawa Y, Kohjima M, Miyagi Y, Yoshimoto T, Kotoh K, Enjoji M, Takayanagi R, Soejima Y, Taketomi A, Yoshizumi T, Maehara Y, Nakamuta M. Inoue S, et al. Among authors: enjoji m. Fukuoka Igaku Zasshi. 2007 Jul;98(7):295-300. Fukuoka Igaku Zasshi. 2007. PMID: 17710894 Free article. Japanese.

10

Early dynamics of viremia in patients with genotype 1b chronic hepatitis C: Peg-IFNalpha2a shows earlier viral decline than peg-IFNalpha2b in combination therapy with ribavirin.

Fujino T, Nakamuta M, Aoyagi Y, Kohjima M, Satoh T, Fukuda M, Ishibashi H, Yatsuhashi H, Enjoji M. Fujino T, et al. Among authors: enjoji m. Med Sci Monit. 2011 Dec;17(12):CR687-91. doi: 10.12659/msm.882127. Med Sci Monit. 2011. PMID: 22129899 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

429 results

Search Page

Filters